Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Sigma-Aldrich Corporation    SIAL   US8265521018

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/24/2014 07/25/2014 07/28/2014 07/29/2014 07/30/2014 Date
102.59(c) 102.98(c) 103.43(c) 103.25(c) 102.3(c) Last
561 556 438 395 549 942 811 111 467 334 Volume
-0.78% +0.38% +0.44% -0.17% -0.92% Change
More quotes
Company
Sigma-Aldrich Corp. operates as a life science and technology material company. It develops, manufactures, purchases and distributes a broad range of biochemical and organic chemicals. The company's biochemical and organic chemical products are used in scientific research, including genomic and... 
Sector
Specialty Chemicals
Calendar
08/27Ex-dividend day
Surperformance© rating of Sigma-Aldrich Corporation
Trading Rating : Investor Rating :
More about the company
Chart SIGMA-ALDRICH CORPORATION
Duration : Period :
Sigma-Aldrich Corporation Technical Analysis Chart | SIAL | US8265521018 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 2 798 M
EBIT 2014 720 M
Net income 2014 520 M
Finance 2014 688 M
Yield 2014 0,90%
Sales 2015 2 931 M
EBIT 2015 767 M
Net income 2015 560 M
Finance 2015 162 M
Yield 2015 0,95%
PER 2014 23,58
PER 2015 21,87
EV / Sales 2014 4,10x
EV / Sales 2015 4,10x
Capitalization 12 171 M
More Financials
Latest news on SIGMA-ALDRICH CORPORATION
1d ago SIGMA ALDRICH : Assigned Patent
2d ago SIGMA ALDRICH : Achieves Record Success in Environmental, Community Initiatives
3d ago SIGMA ALDRICH : purchase order to Sigma Aldrich for Supelco Molecular Imprinted ..
6d ago SIGMA ALDRICH : Presolicitation Notice - Notice of Intent to Sole Source
7d ago SIGMA ALDRICH : Management's Discussion and Analysis of Financial Condition and ..
7d ago SIGMA ALDRICH : NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701..
7d ago SIGMA ALDRICH : Results of Operations and Financial Condition, Financial Stateme..
7d ago SIGMA ALDRICH : NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701..
07/16 Researchers Submit Patent Application, "Methods for Treating Glioblastoma", f..
07/09 SIGMA ALDRICH : Announces Q2 2014 Earnings Conference Call and Cash Dividend
06/24 SIGMA ALDRICH : AGTC and SAFC Create Strategic Partnership to Provide Gene Thera..
06/18 SIGMA ALDRICH : Assigned Patent
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
Sigma-Aldrich Corporation : Income Statement Evolution
More Financials
EPS Revisions
Sigma-Aldrich Corporation : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF